ISBE-AstraZeneca Strategic Alliance Project 5 Ninth meeting of the Strategic Alliance ISBE, University of Manchester 29 September 2003 Measurement of blood.

Slides:

Advertisements

Similar presentations

VBM Voxel-based morphometry

Advertisements

MRI preprocessing and segmentation.

ISMRM Hawaii 2009 slide 1 P.S.Tofts 1,2, M. Cutajar 1,2, I.Gordon 2 1 = Brighton and Sussex Medical School, UK 2 = Institute of Neurology, University College.

Parameters and Trade-offs

McDaniels – Feb 29, Outline Patient 6 question Patient 11 ADC results Abstract for AAPM conference.

Dynamic Contrast Enhanced Imaging and its applications Image Retreat June-05 -Ramtilak Gattu.

Julio Arevalo Perez 1, Kyung K. Peck 2, Robert J. Young 1, Andrei I Holodny 1, Sasan Karimi 1 John K. Lyo 1 1 Department of Radiology 2 Department of Medical.

Julio Arevalo-Perez 1 *, Alissa A Thomas 2 *, Thomas Kaley 2, John Lyo 1, Kyung K Peck 3, Andrei I. Holodny 1, Weiji Shi 4, Zhigang Zhang 4, Robert J Young.

Imaging of bevacizumab treated brain: traditional and emerging concepts Asim K. Bag Joel K Cure Aparna Singhal David Wever Asim K. Bag Joel K Cure Aparna.

MRI Based Lung Perfusion as a Tool to Evaluate Lung Function in Patients Undergoing Radiotherapy for Pulmonary Neoplasms Xiutao Shi, Warren D’Souza, and.

M. D. A NDERSON Cancer Center Magnetic Resonance Imaging: 4.7 T, 40 cm Bruker Biospec James A Bankson, Ph.D. and John D Hazle, Ph.D. Small Animal Cancer.

ISBE-AstraZeneca Strategic Alliance Project 26 Evaluation of Crohn’s disease using T1-weighted dynamic contrast- enhanced MRI (DCE-MRI) Karl Embleton.

ISBE-AstraZeneca Strategic Alliance Project 23 Progress Report Development and assessment of quantitative oxygen-enhanced MRI in patients with obstructive.

MRI-Based Assessment of Neovasculariation in Carotid Plaque – A Novel Risk Marker for Plaque Rupture Lawrence L. Wald, Ph.D. MGH Martinos Center for Biomedical.

MRI FINDING IN LINGUAL HEMANGIOMA M. AMOR, S. MAJDOUB, M. DHIFALLAH, H. ZAGHOUANI, T. RZIGA, H. AMARA, D. BAKIR, C.KRAIEM RADIOLOGY SERVICE, UNIVERSITY.

ISBE-AstraZeneca Strategic Alliance Project 26 Evaluation of Crohn’s disease using T1-weighted dynamic contrast- enhanced MRI (DCE-MRI) Karl Embleton.

MRI-Based Assessment of Neovasculariation in Carotid Plaque – A Novel Risk Marker for Plaque Rupture Michael Jerosch-Herold, PhD Associate Professor of.

ISBE-AstraZeneca Strategic Alliance Project # 42 Modelling DCE-MRI Arterial Input Functions in rats Deirdre McGrath, Strategic Alliance meeting 1 st July.

White Matter Structural Integrity in Healthy Aging Adults and Patients With Alzheimer Disease: A Magnetic Resonance Imaging Study Bartzokis, et al. UCLA.

Characteristic Dynamic Enhancement Pattern of MR imaging for Malignant Thyroid Tumor XIX Symposium Neuroradiologicum Division of Head & Neck radiology.

Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.

Volume 25, Issue 2, Pages (March 2001)

CT scan of the chest. These axial images of the lower chest demonstrate the difference in lung and soft tissue windows. This patient has a history of congenital.

7.3c. Post-Contrast Axial CT of the Brain

Trevor Rose, MD, MPH, Jamie Caracciolo, MD, MBA, Robert Gatenby, MD

Fig. 3. Follow-up MRI (4 weeks later) contrast-enhanced T1-weighted axial (a) and coronal (b) MRI, showed a marked decrease in the extent of the plaque-like.

Luis A. Marcos, Zengmin Yan

Adrian B. Cresswell, Fenella K.S. Welsh, Myrddin Rees HPB

Fig. 1. Axial contrast-enhanced T1-weighted subtraction MR images obtained 150 s after contrast injection in a 49-year-old premenopausal woman treated.

Dynamic Contrast-Enhanced MRI of Malignant Pleural Mesothelioma

Fig year-old female patient with two months of headaches and falls and a remote history of right lung lobectomy for reported benign tumor with MR.

PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma Kemp H Kernstine, MD, PhD, William Stanford, MD, Brian F Mullan,

Lesions that mimic intramedullary tumours.

Trevor Rose, MD, MPH, Jamie Caracciolo, MD, MBA, Robert Gatenby, MD

Volume 126, Issue 3, Pages (March 2004)

Volume 43, Issue 3, Pages (March 2003)

Figure 5 Identification of mucinous carcinoma

7.1b. Contrast coronal T1 Wtd MRI 7.1c. Contrast sagittal T1 Wtd MRI

Hiroki Yamada, Kazuyuki Saito, Mitsuhiko Hokari, Shuta Toru

Idiopathic systemic capillary leak syndrome (Clarkson disease)

Functional imaging in liver tumours

Michael H. Rosenthal, MD, PhD Hiroto Hatabu, MD, PhD

Pathophysiology of the lymphatic drainage of the central nervous system: Implications for pathogenesis and therapy of multiple sclerosis R.O. Weller,

Volume 59, Issue 1, Pages (July 2013)

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Figure 4 Comparison of 7.0T and 3.0T MRI (patients 5 and 6)‏

A 45 YEAR OLD WOMAN WITH PROGRESSIVE WEAKNESS

Synovial volume vs synovial measurements from dynamic contrast enhanced MRI as measures of response in osteoarthritis A.D. Gait, R. Hodgson, M.J. Parkes,

Knee pain and inflammation in the infrapatellar fat pad estimated by conventional and dynamic contrast-enhanced magnetic resonance imaging in obese patients.

Paola Zigrino, Isolde Kuhn, Tobias Bäuerle, Jan Zamek, Jay W

E. Bandak, M. Boesen, H. Bliddal, R. G. C. Riis, H. Gudbergsen, M

Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis Basilia Zingarelli,

Signal intensity is dependent on scaling

Kirsten Brukamp, MD, Simin Goral, MD, Raymond R. Townsend, MD, Frank E

Fig F-FGln shows uptake in human gliomas undergoing progression.

Axial 123I-FP-CIT DaT-SPECT images in a patient with dementia with Lewy bodies (A) and a patient with Alzheimer disease (B). Axial 123I-FP-CIT DaT-SPECT.

A, A 50-year old female patient with acute ischemic stroke (AIS), visible as an area of reduced diffusion (dark region) on the apparent diffusion coefficient.

Metastatic Non-Small Cell Lung Carcinoma With Involvement of Extremity Musculature: Case Report and Review of the Literature Gautam Ramakrishna, MD,

Patient 5, a 33-year-old man presenting with severe headache and sinus congestion. Patient 5, a 33-year-old man presenting with severe headache and sinus.

Axial view MR images of the head, obtained at the time of second presentation.A, T1-weighted MR image (400/15) shows thickening of the dura overlying the.

Fig. 2. Axial contrast-enhanced T1-weighted subtraction MRI obtained 150 s after contrast injection in a 57-year-old post-menopausal woman treated for.

Dynamic contrast-enhancement curves for patients with SLE (blue) and healthy controls (red) according to the brain regions sampled. Dynamic contrast-enhancement.

Sequential axial T1-weighted noncontrast mag-netic resonance images through the posterior fossa of a 52-year-old male with history of multiple sclerosis.

Images from a 62-year-old male patient presenting with a heterogeneous mass in the superior lobe of the right lung. a) Fusion of axial fat-saturated T1-weighted.

A 5-year-old girl with right lateral ventricle choroids plexus papilloma.A, Axial postcontrast T1-weighted image shows an avidly enhancing, intraventricular.

CT scans and data analysis obtained from patient 1

Validation of NAA's cancer specificity in lung cancer.

Diastolic dysfunction in sickle cell

TMEM-mediated vascular permeability is transient and localized.

Patient 4, a 72-year-old man presenting with headache, dysphagia, and progressive hoarseness. Patient 4, a 72-year-old man presenting with headache, dysphagia,

Presentation transcript:

ISBE-AstraZeneca Strategic Alliance Project 5 Ninth meeting of the Strategic Alliance ISBE, University of Manchester 29 September 2003 Measurement of blood volume and endothelial permeability in non-malignant lung disease Progress Report

ISBE-AstraZeneca Strategic Alliance Project 5 Project objective Progress Report To investigate the ability of dynamic parametric imaging to produce meaningful and reproducible images of normal lung parenchyma and lung tissue involved in inflammatory lung diseases

ISBE-AstraZeneca Strategic Alliance Project 5 Background Progress Report Existing T 1 -weighted dynamic contrast enhanced MRI study of neoplastic lung disease (-separate University of Manchester/ AstraZeneca collaboration) Dynamic data modelled to obtain transfer constant K trans (related to permeability), vascular blood volume v b, extravascular extracellular space volume v e Investigate contrast enhancement in areas of lung tissue outside tumour

ISBE-AstraZeneca Strategic Alliance Project 5 Axial T1-weighted images indicating ROI position for lung parenchyma measurements. Measurements were possible in 3 of 4 patients. Pats 1,2,4. Grey scale windowed to demonstrate the presence of signal in the ROIs Progress Report

ISBE-AstraZeneca Strategic Alliance Project 5 Axial T1-weighted images indicating ROI position for lung parenchyma measurements. Measurements were possible in 3 of 4 patients. Pats 1,2,4. Grey scale windowed to demonstrate the presence of signal in the ROIs Progress Report

ISBE-AstraZeneca Strategic Alliance Project 5 Axial T1-weighted images indicating ROI position for lung parenchyma measurements. Measurements were possible in 3 of 4 patients. Pats 1,2,4. Grey scale windowed to demonstrate the presence of signal in the ROIs Progress Report

ISBE-AstraZeneca Strategic Alliance Project 5 lung parenchyma ROI concentration time courses and model fits. Progress Report

ISBE-AstraZeneca Strategic Alliance Project 5 lung parenchyma ROI concentration time courses and model fits. Progress Report

ISBE-AstraZeneca Strategic Alliance Project 5 lung parenchyma ROI concentration time courses and model fits. Progress Report